| Product Name | EphB4 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | EPHB4 antibody; HTK antibody; MYK1 antibody; TYRO11 antibody; Ephrin type-B receptor 4 antibody; Hepatoma transmembrane kinase antibody; Tyrosine-protein kinase TYRO11 antibody; |
| Product description | Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene binds to ephrin-B2 and plays an essential role in vascular development. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human EPHB4. AA range:571-620 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIHCIF |
| WB:1:500-1:2000 IHC:1:100-1:300 IF:1:100-1:500 |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Alternative Names | EPHB4 antibody HTK antibody MYK1 antibody TYRO11 antibody Ephrin type-B receptor 4 antibody Hepatoma transmembrane kinase antibody Tyrosine-protein kinase TYRO11 antibody |
|---|---|
| Molecular Weight(MW) | 108 kDa |
| SwissProt ID | P54760 |
|---|
| Positive Control | Epithelium,Ovary,Pancreas,Spleen, |
|---|---|
| Application Notes | WB:1:500-1:2000 IHC:1:100-1:300 IF:1:100-1:500 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
